Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of myopericarditis – an inflammatory condition of the heart muscle – following mRNA COVID19 vaccination, with the highest risks seen in young males following a second vaccine dose. Similar findings have been reported by other investigators working with CDC health scientists. RSI investigators noted that the risk of myopericarditis is appreciably higher in individuals with COVID 19 than the risk associated with vaccination.
More RSI News
Country Foods Forum
Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods…
Workshop on Evidence Integration December 5-6, 2019
Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre…
RSI wins 2019 Consulting Engineers of Ontario Award of Merit
Risk Sciences International (RSI), as members of a consulting team with Stantec, along with the Ontario First Nations Technical Services Corporation (OFNTSC), has won an Award of Merit from the…
Updated CSA Technical Guide for Infrastructure in Permafrost published
A second updated edition of the CSA national permafrost standard was published on May 21, 2019 and features climate and climate change information provided by…